*Self-collected vaginal specimens can be tested as an alternative specimen type when cervical sampling is either contraindicated or cervical samples otherwise cannot be obtained.
†The BD Onclarity™ HPV Assay is the only FDA-approved HPV test which provides the capability for individually genotyping six high-risk types and three genotype groups.
‡The BD Onclarity™ HPV Assay is the only FDA-approved HPV test which provides the capability for individually genotyping six high-risk types and three genotype groups.
- BD Onclarity™ HPV Assay US Package Insert [8089894].
- Martinelli M, et al. Microbiol Spectr. 2024;12(3):e0287223. doi:10.1128/spectrum.02872-23
- Cancers Caused by HPV. Centers for Disease Control and Prevention. Published March 3, 2025. Accessed April 29, 2026, at https://www.cdc.gov/hpv/about/cancers-caused-by-hpv.html
- CDC. Cancer. Basic Information about HPV and Cancer. Published 2024. https://www.cdc.gov/cancer/hpv/basic-information.html
- Wentzensen N, Massad LS, Clarke MA, et al. Self-Collected Vaginal Specimens for HPV Testing: Recommendations from the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee. J Low Genit Tract Dis. 2025;29(2):144-152. doi:10.1097/LGT.0000000000000885
- ACOG. Screening for Cervical Cancer. Obstetrics & Gynecology. Accessed April 28, 2026, at https://journals.lww.com/greenjournal/fulltext/9900/screening_for_cervical_cancer.1515.aspx
- Xue H. J Cancer. 2021; 12(14): 4332-4340.
- American Cancer Society. “Cervical Cancer Screening Guidelines.” American Cancer Society, 1 July 2025, www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-staging/cervical-cancer-screening-guidelines.html
- Scarinci IC, Garcia FA, Kobetz E, Partridge EE, Brandt HM et al. (2010) Cervical cancer prevention: new tools and old barriers. Cancer 116 (11): 2531-2542.
- Subramaniam A, Fauci JM, Schneider KE, et al. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?. J Low Genit Tract Dis. 2011;15(2):110-113. doi:10.1097/LGT.0b013e3181f515a2.
- BD Onclarity™ HPV Assay US Package Insert [8089894].
- Centers for Disease Control and Prevention. Cancers Caused by HPV. Published March 3, 2025. Accessed April 29, 2026, at https://www.cdc.gov/hpv/about/cancers-caused-by-hpv.html
- Centers for Disease Control and Prevention. Basic Information about HPV and Cancer. Published September 17, 2024. Accessed April 29, 2026, at https://www.cdc.gov/cancer/hpv/basic-information.html
- Scarinci IC, Garcia FA, Kobetz E, Partridge EE, Brandt HM et al. (2010) Cervical cancer prevention: new tools and old barriers. Cancer 116 (11): 2531-2542.
- Centers for Disease Control and Prevention. Cervical Cancer Risk Factors. Published December 11, 2024. Accessed April 29, 2026, at https://www.cdc.gov/cervical-cancer/risk-factors/index.html
- Subramaniam A, Fauci JM, Schneider KE, et al. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?. J Low Genit Tract Dis.2011;15(2):110-113. doi:10.1097/LGT.0b013e3181f515a2
- National Cancer Institute. ACS’s Updated Cervical Cancer Screening Guidelines Explained. Published September 18, 2011. Accessed April 29, 2026, at https://www.cancer.gov/news-events/cancercurrents-blog/2020/cervical-cancer-screening-hpv-test-guideline
- Centers for Disease Control and Prevention. Sexually Transmitted Infections (STI) Treatment Guidelines, 2021: HPV-Associated Cancers and Precancers. Last reviewed July 22, 2021. Accessed April 29, 2026, at https://www.cdc.gov/std/treatment-guidelines/hpv-cancer.htm